is wegovy a glp 1 drug GLP-1 obesity drugs cleared of suicide warning Novo Nordisk launches its Wegovy
Description
Obesity is a major driver of US health care costs, totaling almost $173 billion annually, according to the CDC in 2024
Together, these two pathways create a multi-layered approach to appetite control that phentermine simply cannot match
In agreement with experimental studies, GLP-1 analogues, particularly liraglutide, sustain the maintenance of -cell function in obese individuals with early T2D, and these effects are presumably independent of weight loss (42, 43)
doi:10.3390/ijms22031296 27
